Metabolomic signatures of drug response phenotypes for ketamine and esketamine in subjects with refractory major depressive disorder: new mechanistic insights for rapid acting antidepressants
about
Peripheral biomarkers of major depression and antidepressant treatment response: Current knowledge and future outlooks.Personalised Interventions-A Precision Approach for the Next Generation of Dietary Intervention Studies.Drugs with antidepressant properties affect tryptophan metabolites differently in rodent models with depression-like behavior.Pramlintide: The Effects of a Single Drug Injection on Blood Phosphatidylcholine Profile for Alzheimer's Disease.Plasma metabolomic profiling of a ketamine and placebo crossover trial of major depressive disorder and healthy control subjects
P2860
Metabolomic signatures of drug response phenotypes for ketamine and esketamine in subjects with refractory major depressive disorder: new mechanistic insights for rapid acting antidepressants
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Metabolomic signatures of drug ...... r rapid acting antidepressants
@en
Metabolomic signatures of drug ...... rapid acting antidepressants.
@nl
type
label
Metabolomic signatures of drug ...... r rapid acting antidepressants
@en
Metabolomic signatures of drug ...... rapid acting antidepressants.
@nl
prefLabel
Metabolomic signatures of drug ...... r rapid acting antidepressants
@en
Metabolomic signatures of drug ...... rapid acting antidepressants.
@nl
P2093
P2860
P50
P356
P1476
Metabolomic signatures of drug ...... r rapid acting antidepressants
@en
P2093
P2860
P2888
P356
10.1038/TP.2016.145
P577
2016-09-20T00:00:00Z
P6179
1037129243